Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Shoemaker

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
JACC. Clinical Electrophysiology|August 22, 2020
Conduction Recovery After Cavotricuspid Isthmus Ablation When Performed With or Without Concomitant Atrial Fibrillation AblationZachary T Yoneda, M Benjamin Shoemaker, Travis Richardson, et al.
Journal of Cardiovascular Electrophysiology|May 22, 2022
Durable pulmonary vein isolation with diffuse posterior left atrial ablation using low-flow, median power, short-duration strategyDan L Li, Majd El-Harasis, Jay A Montgomery, et al.
BMC Pharmacology & Toxicology|January 8, 2020
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trialLisa M Pitchford, Patricia M Driver, John C Fuller, et al.
Journal of the American College of Cardiology|May 7, 2011
Left atrial hypertension after repeated catheter ablations for atrial fibrillationM Benjamin Shoemaker, Anna R Hemnes, Ivan M Robbins, et al.
Heart Rhythm|November 27, 2012
Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablationM Benjamin Shoemaker, Raafia Muhammad, Babar Parvez, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
Plos One|September 8, 2017
Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotypeMaureen Farrell, Zachary Yoneda, Jay Montgomery, et al.
Journal of Arrhythmia|March 8, 2016
Measurement of diffuse ventricular fibrosis with myocardial T1 in patients with atrial fibrillationJay A Montgomery, Wissam Abdallah, Zachary T Yoneda, et al.
Circulation. Arrhythmia and Electrophysiology|January 9, 2015
Genetic and clinical risk prediction model for postoperative atrial fibrillationMatthew J Kolek, J Daniel Muehlschlegel, William S Bush, et al.
Circulation|December 28, 2018
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic DiscoveryKrishna G Aragam, Mark Chaffin, Rebecca T Levinson, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
JACC. Clinical Electrophysiology|August 22, 2020
Conduction Recovery After Cavotricuspid Isthmus Ablation When Performed With or Without Concomitant Atrial Fibrillation AblationZachary T Yoneda, M Benjamin Shoemaker, Travis Richardson, et al.
Journal of Cardiovascular Electrophysiology|May 22, 2022
Durable pulmonary vein isolation with diffuse posterior left atrial ablation using low-flow, median power, short-duration strategyDan L Li, Majd El-Harasis, Jay A Montgomery, et al.
BMC Pharmacology & Toxicology|January 8, 2020
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trialLisa M Pitchford, Patricia M Driver, John C Fuller, et al.
Journal of the American College of Cardiology|May 7, 2011
Left atrial hypertension after repeated catheter ablations for atrial fibrillationM Benjamin Shoemaker, Anna R Hemnes, Ivan M Robbins, et al.
Heart Rhythm|November 27, 2012
Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablationM Benjamin Shoemaker, Raafia Muhammad, Babar Parvez, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
Plos One|September 8, 2017
Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotypeMaureen Farrell, Zachary Yoneda, Jay Montgomery, et al.
Journal of Arrhythmia|March 8, 2016
Measurement of diffuse ventricular fibrosis with myocardial T1 in patients with atrial fibrillationJay A Montgomery, Wissam Abdallah, Zachary T Yoneda, et al.
Circulation. Arrhythmia and Electrophysiology|January 9, 2015
Genetic and clinical risk prediction model for postoperative atrial fibrillationMatthew J Kolek, J Daniel Muehlschlegel, William S Bush, et al.
Circulation|December 28, 2018
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic DiscoveryKrishna G Aragam, Mark Chaffin, Rebecca T Levinson, et al.
Pageof 14